A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Brain Research

• Publication date

  2009-01-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.brainres.2008.10.063PMID 19022231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.

  2008cited by this paper
• Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.

  2008cited by this paper
• Comparative activity of antiemetic drugs.

  2007cited by this paper
• Similarities of the neuronal circuit for the induction of fictive vomiting between ferrets and dogs.

  2007cited by this paper
• [Relationship between neurotransmitter blood noradrenalin and nausea/emesis after chemotherapy for lung cancer].

  2006cited by this paper
• 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy

  2006cited by this paper
• Treatment of nausea and vomiting: gaps in our knowledge.

  2006cited by this paper
• Differential activity of drugs to induce emesis and pica behavior in Suncus murinus (house musk shrew) and rats.

  2004cited by this paper
• The Role of Tachykinins and the Tachykinin NK1 Receptor in Nausea and Emesis

  2004cited by this paper
• 5-hydroxytryptamine (5-HT) concentrations in the hippocampus, the hypothalamus and the medulla oblongata related to cisplatin-induced pica of rats.

  2003cited by this paper
• Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity.

  2003cited by this paper
• Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew).

  2003cited by this paper
• Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover.

  2003cited by this paper
• Influences of dibutyryl cyclic adenosine monophosphate and forskolin on human sperm motility in vitro.

  2003cited by this paper
• Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.

  2003cited by this paper
• Antiemetic effect of a tachykinin NK1 receptor antagonist GR205171 on cisplatin-induced early and delayed emesis in the pigeon.

  2003cited by this paper
• The effects of nabumetone, a cyclooxygenase-2 inhibitor, on cisplatin-induced 5-hydroxytryptamine release from the isolated rat ileum.

  2001cited by this paper
• Central neurocircuitry associated with emesis.

  2001cited by this paper
• Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone.

  2001cited by this paper
• Cisplatin-induced emesis in the cat: effect of granisetron and dexamethasone.

  2000cited by this paper
• Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.

  1999cited by this paper
• Effects of granisetron and its combination with dexamethasone on cisplatin-induced delayed emesis in the ferret.

  1998cited by this paper
• Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis

  1998cited by this paper
• Urinary 5-hydroxyindoleacetic acid (5-HIAA) excretion during multiple-day high-dose chemotherapy.

  1998cited by this paper
• The relationship between parameters of serotonin metabolism and emetogenic potential of platinum-based chemotherapy regimens

  1997cited by this paper
• Physiology of Chemotherapy-Induced Emesis and Antiemetic Therapy

  1997cited by this paper
• Effect of cisplatin on dopamine release from PC12 cells.

  1996cited by this paper
• The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret

  1996cited by this paper
• Serotonin mechanisms in chemotherapy-induced emesis in cancer patients.

  1996cited by this paper
• The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus.

  1996cited by this paper
• The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.

  1995cited by this paper
• How do toxic emetic stimuli cause 5-HT release in the gut and brain?

  1995cited by this paper
• Antagonism of serotonin3 (5-HT3) receptors within the blood-brain barrier prevents cisplatin-induced emesis in dogs.

  1995cited by this paper
• Urinary serotonin metabolite excretion during cisplatin chemotherapy

  1993cited by this paper
• Vagal afferent fibers and peripheral 5-HT3 receptors mediate cisplatin-induced emesis in dogs.

  1992cited by this paper
• Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs.

  1992cited by this paper
• DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.

  1992cited by this paper
• Vagotomy and ondansetron (5-HT3 antagonist) inhibited the increase of serotonin concentration induced by cytotoxic drugs in the area postrema of ferrets

  1992cited by this paper
• Cisplatin-induced emesis in Suncus murinus.

  1992cited by this paper
• Cisplatin induced emesis: preliminary results indicative of changes in plasma levels of 5-hydroxytryptamine.

  1990cited by this paper
• Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret.

  1990cited by this paper
• 5‐HT3 receptor antagonists injected into the area postrema inhibit cisplatin‐induced emesis in the ferret

  1989cited by this paper
• The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride

  1988cited by this paper
• Respiratory mechanics of vomiting in decerebrate cats.

  1974cited by this paper

• The Cannabinoid CB1 Receptor Inverse Agonist/Antagonist SR141716A Activates the Adenylate Cyclase/PKA Signaling Pathway Among Other Intracellular Emetic Signals to Evoke Vomiting in Least Shrews (Cryptotis parva)

  2025cites this paper
• A re-consideration of neural/receptor mechanisms in chemotherapy-induced nausea and vomiting: current scenario and future perspective

  2023cites this paper
• RNA sequencing least shrew (Cryptotis parva) brainstem and gut transcripts following administration of a selective substance P neurokinin NK1 receptor agonist and antagonist expands genomics resources for emesis research

  2023cites this paper
• Evidence for Bell-Shaped Dose-Response Emetic Effects of Temsirolimus and Analogs: The Broad-Spectrum Antiemetic Efficacy of a Large Dose of Temsirolimus Against Diverse Emetogens in the Least Shrew (Cryptotis parva)

  2022cites this paper
• Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis.

  2021cites this paper
• Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems

  2021cites this paper
• The HCN Channel Blocker ZD7288 Induces Emesis in the Least Shrew (Cryptotis parva)

  2021cites this paper
• Involvement of 5-Serotonin and Substance p Pathways in Dichroa Alkali Salt-Induced Acute Pica in Rats

  2021cites this paper
• Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva)

  2020cites this paper
• Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK1R) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva)

  2019cites this paper
• Symptom Management in Gastrointestinal Cancers

  2019cites this paper
• The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).

  2019cites this paper
• Role of neurotransmitters 5-hydroxytryptamine and substance P in anorexia induction following oral exposure to the trichothecene T-2 toxin.

  2019cites this paper
• Synthesis, Characterization and Biocompatibility of N-palmitoyl L-alanine-based Organogels as Sustained Implants of Granisetron and Evaluation of their Antiemetic Effect

  2018cites this paper
• Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences

  2018cites this paper
• Anorectic responses to T-2 toxin, HT-2 toxin, diacetoxyscirpenol and neosolaniol correspond to plasma elevations of neurotransmitters 5-hydroxytryptamine and substance P.

  2018cites this paper
• Role of Calcium in Vomiting

  2018cites this paper
• Clinical Potential of a New Class of Antiemetic for the Prevention of Chemotherapy-Evoked Acute- and Delayed Vomiting: Supportive Evidence from the Least Shrew ( Cryptotis Parva ) Model of Emesis

  2017cites this paper
• Intracellular vomit signals and cascades downstream of emetic receptors: Evidence from the least shrew (Cryptotis parva) model of vomiting.

  2017cites this paper
• Erratum to: Synthetic and natural antioxidants attenuate cisplatin-induced vomiting

  2017cites this paper
• Synthetic and natural antioxidants attenuate cisplatin-induced vomiting

  2017cites this paper
• Pulmonary , gastrointestinal and urogenital pharmacology The anti-asthmatic drug pranlukast suppresses the delayed-phase vomiting and reverses intracellular indices of emesis evoked by cisplatin in the least shrew ( Cryptotis parva )

  2017influential citation
• Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.

  2017cites this paper
• Methotrexate causes acute hyperplasia of enterochromaffin cells containing substance P in the intestinal mucosa of rats.

  2017cites this paper
• Ca2+ signaling and emesis: Recent progress and new perspectives.

  2017cites this paper
• The Physiology and Pharmacology of Nausea and Vomiting Induced by Anticancer Chemotherapy in Humans

  2016cites this paper
• Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1/2, PKA and PKC activation.

  2015influential citation
• Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron).

  2015cites this paper
• Anti-emetic mechanisms of zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates

  2015cites this paper
• L‐Type Calcium Channels Contribute to 5‐HT3‐Receptor‐Evoked CaMKIIα and ERK Activation and Induction of Emesis in the Least Shrew (Cryptotis parva)

  2015cites this paper
• APREPITANT, A NEWER ANTIEMETIC IN CHEMOTHERAPY INDUCED NAUSEA AND VOMITING

  2015cites this paper
• Cyclophosphamide causes activation of protein kinase A (PKA) in the brainstem of vomiting least shrews (Cryptotis parva).

  2014cites this paper
• Netupitant and palonosetron trigger NK1 receptor internalization in NG108-15 cells

  2014cites this paper
• Attenuation of Cisplatin-Induced Emetogenesis by Standardized Bacopa monnieri Extracts in the Pigeon: Behavioral and Neurochemical Correlations

  2014cites this paper
• Evaluating the various phases of cisplatin-induced emesis in rats

  2014cites this paper
• Serotonin 5-HT3 Receptor-Mediated Vomiting Occurs via the Activation of Ca2+/CaMKII-Dependent ERK1/2 Signaling in the Least Shrew (Cryptotis parva)

  2014cites this paper
• The medical implications of gastrointestinal vagal afferent pathways in nausea and vomiting.

  2014cites this paper
• Author's response to reviews Title:Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates Authors:

  2014cites this paper
• Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.

  2014cites this paper
• Involvement of substance P in the development of cisplatin‐induced acute and delayed pica in rats

  2014cites this paper
• Cisplatin causes over-expression of tachykinin NK(1) receptors and increases ERK1/2- and PKA- phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotis parva) brainstem.

  2013cites this paper
• EVALUATION OF SOME SELECTED MEDICINAL PLANTS AND THEIR COMBINATIONS IN CISPLATIN INDUCED VOMITING IN VOMIT MODEL(S); BEHAVIORAL NEUROCHEMICAL CORRELATES

  2013cites this paper
• Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients

  2013cites this paper
• Pathology of emesis: its autonomic basis.

  2013cites this paper
• Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.

  2012cites this paper
• Distribution of Serotonin-immunoreactive Enterochromaffin Cells in the Gastrointestinal Tract of the Least Shrew (Cryptotis parva)

  2012cites this paper
• Pemirolast reduces cisplatin-induced kaolin intake in rats.

  2011cites this paper
• Cisplatin‐induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica

  2010cites this paper
• Differential temporal changes in brain and gut substance P mRNA expression throughout the time-course of cisplatin-induced vomiting in the least shrew (Cryptotis parva).

  2010cites this paper
• Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting

  2010cites this paper
• Pranlukast prevents cysteinyl leukotriene‐induced emesis in the least shrew (Cryptotis parva)

  2010cites this paper
• Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).

  2009influential citation
• Ablation of least shrew central neurokinin NK1 receptors reduces GR73632-induced vomiting.

  2009cites this paper
• Serotonin and the GI tract

  2009cites this paper
• Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting.

  2009cites this paper